Plus   Neg

AECOM Appoints Jennifer Aument As Chief Executive Of Global Transportation Business - Quick Facts

AECOM Inc. (ACM), an infrastructure consulting firm, said Tuesday it has appointed Jennifer Aument as chief executive of its global Transportation business and Drew Jeter as chief executive of its global Program Management business. Aument's appointment is effective April 5, 2021, and Jeter's appointment is effective January 25, 2021.

In her new role, Aument will oversee AECOM's global Transportation design business to drive innovative transportation solutions that better advance its clients' goals of delivering safe, sustainable and cost-effective transportation systems.

Jeter will lead AECOM's global Program Management business, focusing on leveraging the company's technical expertise to provide front-end advisory services for large capital programs and to more holistically manage clients' programs to best achieve their objectives throughout the project lifecycle.

Aument joins AECOM from Transurban, where she served most recently as president and CEO of its North American business. Aument oversaw development, financing, delivery and operations of major toll road infrastructure in the United States and Canada. This includes the company's $4 billion Express Lanes network in Virginia.

Jeter has more than 35 years of experience leading the development and delivery of technically complex, multi-billion-dollar facilities and infrastructure. He comes to AECOM after holding global program management leadership roles at Hill International, Jacobs and CH2M where he oversaw the delivery of more than $300 billion of capital infrastructure programs.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Walmart Inc. has launched a nationwide drive to boost COVID-19 vaccination rates by reaching out to more residents in vulnerable communities. The retail giant will organize a series of community events at 43 locations in 18 states to administer the COVID-19 vaccine. Walmart said it plans to continue these new events over the next several weeks as vaccine allocations allow. Pfizer Inc. (PFE) and OPKO Health Inc. (OPK) announced Friday that the European Medicines Agency or EMA has validated for review the Marketing Authorization Application for somatrogon. Pfizer expects a decision from the European Commission in 2022. The company said somatrogon is a long-acting recombinant... German telecom giant Deutsche Telekom AG reported Friday strong growth in fourth-quarter profit mainly driven by T-Mobile US results following the takeover of the competitor Sprint. Looking ahead for fiscal 2021, the company projects higher adjusted EBITDA AL, a key earnings metric.
Follow RTT